Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.
Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.
复制标题
DOI:
10.18632/aging.101355
复制
发表时间:
2017-12-28
期刊:
影响因子:
--
通讯作者:
Mirnezami AH
中科院分区:
文献类型:
--
作者:
Bhome R;Goh RW;Bullock MD;Pillar N;Thirdborough SM;Mellone M;Mirnezami R;Galea D;Veselkov K;Gu Q;Underwood TJ;Primrose JN;De Wever O;Shomron N;Sayan AE;Mirnezami AH
Colorectal cancer is a global disease with increasing incidence. Mortality is largely attributed to metastatic spread and therefore, a mechanistic dissection of the signals which influence tumor progression is needed. Cancer stroma plays a critical role in tumor proliferation, invasion and chemoresistance. Here, we sought to identify and characterize exosomal microRNAs as mediators of stromal-tumor signaling. In vitro, we demonstrated that fibroblast exosomes are transferred to colorectal cancer cells, with a resultant increase in cellular microRNA levels, impacting proliferation and chemoresistance. To probe this further, exosomal microRNAs were profiled from paired patient-derived normal and cancer-associated fibroblasts, from an ongoing prospective biomarker study. An exosomal cancer-associated fibroblast signature consisting of microRNAs 329, 181a, 199b, 382, 215 and 21 was identified. Of these, miR-21 had highest abundance and was enriched in exosomes. Orthotopic xenografts established with miR-21-overexpressing fibroblasts and CRC cells led to increased liver metastases compared to those established with control fibroblasts. Our data provide a novel stromal exosome signature in colorectal cancer, which has potential for biomarker validation. Furthermore, we confirmed the importance of stromal miR-21 in colorectal cancer progression using an orthotopic model, and propose that exosomes are a vehicle for miR-21 transfer between stromal fibroblasts and cancer cells.
登录
查看更多内容
影响因子:
64.5
作者:
Boelens MC;Wu TJ;Nabet BY;Xu B;Qiu Y;Yoon T;Azzam DJ;Twyman-Saint Victor C;Wiemann BZ;Ishwaran H;Ter Brugge PJ;Jonkers J;Slingerland J;Minn AJ
通讯作者:
Minn AJ
影响因子:
21.3
作者:
Costa-Silva B;Aiello NM;Ocean AJ;Singh S;Zhang H;Thakur BK;Becker A;Hoshino A;Mark MT;Molina H;Xiang J;Zhang T;Theilen TM;García-Santos G;Williams C;Ararso Y;Huang Y;Rodrigues G;Shen TL;Labori KJ;Lothe IM;Kure EH;Hernandez J;Doussot A;Ebbesen SH;Grandgenett PM;Hollingsworth MA;Jain M;Mallya K;Batra SK;Jarnagin WR;Schwartz RE;Matei I;Peinado H;Stanger BZ;Bromberg J;Lyden D
通讯作者:
Lyden D
DOI:
10.1016/j.nhtm.2016.03.001
发表时间:
2016-01
期刊:
New horizons in translational medicine
影响因子:
--
作者:
Bhome R;Al Saihati HA;Goh RW;Bullock MD;Primrose JN;Thomas GJ;Sayan AE;Mirnezami AH
通讯作者:
Mirnezami AH
影响因子:
5.5
作者:
Bhome R;Bullock MD;Al Saihati HA;Goh RW;Primrose JN;Sayan AE;Mirnezami AH
通讯作者:
Mirnezami AH
影响因子:
8.8
作者:
Calvo F;Ranftl R;Hooper S;Farrugia AJ;Moeendarbary E;Bruckbauer A;Batista F;Charras G;Sahai E
通讯作者:
Sahai E